All In Biotech

Drug Trial Radar · NCT06988553

A Phase Ib Study of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes Mellitus

A Phase Ib, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AZD5004 in Chinese Participants With Overweight/Obesity With or Without Type 2 Diabetes Mellitus

Last checked: Nov 19, 2026Latest source record: Dec 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

45

Actual

Start

Jun 17, 2025

Primary completion

Nov 28, 2025

Study completion Nov 28, 2025

Sponsor

Lead sponsor
EccogeneIndustry
Sponsor type
Industry
First posted
May 25, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, tolerability, and PK of AZD5004 compared with placebo in Chinese participants with overweight/obesity with or without T2DM.

Conditions

  • Obesity or Overweight
  • Type 2 Diabetes

Interventions

  • AZD5004Drug

    AZD5004 will be administered as an oral tablet once daily.

  • PlaceboDrug

    Placebo will be administered as an oral tablet once daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with adverse events (AEs), serious adverse events (SAEs), adverse event leading to the discontinuation of study intervention (DAEs), death, and Adverse events of special interest (AESIs)Time frame: From baseline to week 16.

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • The Fourth Affiliated Hospital of Harbin Medical University

    Ha’erbin, China

  • The Second People's Hospital of Hefei

    Hefei, China

  • Jinan Central Hospital

    Jinan, China

  • Shanghai Pudong New District People's Hospital

    Shanghai, China

  • General Hospital of Tianjin Medical University

    Tianjin, China

  • West China Hospital, Sichuan University

    Chengdu, Sichuan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.